Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gilad, Litvin"'
Autor:
Clara C. Chan, Eyal Cohen, David S. Rootman, Alfonso Iovieno, Nizar Din, Amit Dahan, Gilad Litvin
Publikováno v:
Cornea. 41:385-389
PURPOSE We describe the first known use of telementoring in corneal surgery and technology combining a 3-dimensional microscope system, 5G live streaming technology, group chat software, and a virtual reality headset for intercontinental surgical sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f01f68ce3523d29a795d83cb1863483
https://doi.org/10.1097/ico.0000000000002921
https://doi.org/10.1097/ico.0000000000002921
Publikováno v:
Eye (London, England).
To describe the first clinical implantation of the CorNeat™ keratoprosthesis, which utilizes a polymeric scaffold for biointegration within ocular tissue.The CorNeat keratoprosthesis was implanted in the right eye of a patient with bilateral cornea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5cc3a706a034b41a78007b601590088
https://pubmed.ncbi.nlm.nih.gov/35650323
https://pubmed.ncbi.nlm.nih.gov/35650323
Autor:
Noa Chetrit, Pnina Fishman, William D Kerns, Kenneth A. Jacobson, Irina S. Barequet, Motti Farbstein, Sara Bar Yehuda, Hanna J. Garzozi, Gil Sartani, Michael H. Silverman, Gilad Litvin, Erez Bakshi, Oren Tomkins, David Zadok, Ilan Cohn, Zivit Harpaz, Fanni Segev, David Bristol, Sari Fishman, David Varssano, Isaac Avni
Publikováno v:
Ophthalmology. 117:1287-1293
Objective To explore the safety and efficacy of CF101, an A 3 adenosine receptor agonist, in patients with moderate to severe dry eye syndrome. Design Phase 2, multicenter, randomized, double-masked, placebo-controlled, parallel-group study. Particip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::892ce353f39cb2ceabc184845b3441f6
https://doi.org/10.1016/j.ophtha.2009.11.029
https://doi.org/10.1016/j.ophtha.2009.11.029
Autor:
Arie L. Marcovich, Gilad Litvin, Michael Rotenberg, Shmuel Ben Eliahu, Guy Kleinmann, David Zadok
Publikováno v:
Journal of cataract and refractive surgery. 40(7)
Purpose To determine the ability of moxifloxacin to penetrate the rabbit eye after corneal collagen crosslinking (CXL) with riboflavin and ultraviolet-A light irradiation. Setting Harlan Biotech Israel, Rehovot, Israel. Design Experimental study. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef761fc33024a01bd860994a12652e8
https://pubmed.ncbi.nlm.nih.gov/24878254
https://pubmed.ncbi.nlm.nih.gov/24878254
Autor:
Isaac, Avni, Hanna J, Garzozi, Irina S, Barequet, Fanni, Segev, David, Varssano, Gil, Sartani, Noa, Chetrit, Erez, Bakshi, David, Zadok, Oren, Tomkins, Gilad, Litvin, Kenneth A, Jacobson, Sari, Fishman, Zivit, Harpaz, Motti, Farbstein, Sara Bar, Yehuda, Michael H, Silverman, William D, Kerns, David R, Bristol, Ilan, Cohn, Pnina, Fishman
To explore the safety and efficacy of CF101, an A(3) adenosine receptor agonist, in patients with moderate to severe dry eye syndrome.Phase 2, multicenter, randomized, double-masked, placebo-controlled, parallel-group study.Sixty-eight patients compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9d5658962bd6a6636faf5f51c38010f3
https://europepmc.org/articles/PMC3668568/
https://europepmc.org/articles/PMC3668568/
